Related Experiment Videos
T-cell oncogene rhombotin-2 interacts with retinoblastoma-binding protein 2
1Department of Virology, St Jude Children's Research Hospital, University of Tennessee, Memphis 38101, USA.
Oncogene
|April 3, 1997
Summary
Rhombotin-2 (RBTN2) interacts with retinoblastoma-binding protein 2 (RBP2), revealing new roles for RBTN2 beyond blood cell development. This interaction enhances transcription, suggesting RBTN2 modulates RBP2 activity and retinoblastoma protein function.
Area of Science:
- Molecular Biology
- Protein Interactions
- Gene Regulation
Background:
- The LIM domain protein rhombotin-2 (RBTN2) is involved in erythropoiesis and T-cell leukemogenesis.
- RBTN2's expression in non-hematopoietic tissues suggests broader functions.
- Diverse functions are likely mediated by interactions with various protein partners.
Purpose of the Study:
- To identify novel protein partners of RBTN2.
- To elucidate the functional consequences of RBTN2 interactions.
Main Methods:
- Yeast two-hybrid screening of a human cDNA library using the RBTN2 LIM domain.
- In vitro binding assays and co-immunoprecipitation to confirm interactions.
- Deletion analysis to map the interaction domains.
Main Results:
- Retinoblastoma-binding protein 2 (RBP2) was identified as an RBTN2 interacting partner.
- The interaction involves the second LIM domain of RBTN2 and the C-terminus of RBP2.
- Co-expression of RBTN2 and RBP2 resulted in enhanced in vitro transcription compared to RBTN2 alone.
Conclusions:
- RBTN2 physically interacts with RBP2.
- This interaction suggests RBTN2 may directly modulate RBP2 activity.
- RBTN2 binding to RBP2 may indirectly influence retinoblastoma protein functions.